Results 291 to 300 of about 173,203 (312)

Associations among serum levels of MMP-1, MMP-2, and METAVIR fibrosis score in patients with nonalcoholic fatty liver disease. [PDF]

Gastroenterol Hepatol Bed Bench
Odkhuu E, Amgalan K, Galsan U, Namkhai UO, Dorjgotov B, Battulga A, Tserendorj BE, Renchindorj A, Ochirchuulgan B, Unurbat E, Bayanzul S.   +10 more
europepmc   +1 more source

Sex-Stratified Prediction Models for 5-Year Nonalcoholic Fatty Liver Disease Risk in Thyroid Cancer Patients: A Nationwide Cohort Study. [PDF]

Biomedicines
Cho YB, Park KS.
europepmc   +1 more source

Disrupted host-microbiota crosstalk promotes nonalcoholic fatty liver disease progression by impaired mitophagy. [PDF]

Microbiol Spectr
Yin W, Gao W, Yang Y, Lin W, Chen W, Zhu X, Zhu R, Zhu L, Jiao N.   +8 more
europepmc   +1 more source

Acetyl-CoA Carboxylase Inhibitors for Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. [PDF]

Pharmaceuticals (Basel)
Hasanatuludhhiyah N, Mustika A, Kalanjati VP, Miftahussurur M, Uemura N.   +4 more
europepmc   +1 more source

Development and Validation of Machine Learning-Based Marker for Early Detection and Prognosis Stratification of Nonalcoholic Fatty Liver Disease. [PDF]

Adv Sci (Weinh)
Xiao L, Zeng L, Wang J, Hong C, Zhang Z, Wu C, Cui H, Li Y, Li R, Liang S, Deng Q, Li W, Zou X, Ma P, Liu L.   +14 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Diagnosis and Management of Nonalcoholic Fatty Liver Disease.

Journal of the American Medical Association (JAMA), 2023
This JAMA Clinical Guidelines Synopsis summarizes the American Association of Clinical Endocrinology’s 2022 clinical practice guideline for diagnosis and management of nonalcoholic fatty liver disease.
Peggy B Leung, Andrew M Davis, Sonal Kumar   +2 more
semanticscholar   +1 more source

Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2014 to 2018 in Japan: A large‐scale multicenter retrospective study

Hepatology Research, 2023
The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing worldwide. The aim of this study was to determine the recent prevalence and clinical characteristics of NAFLD in Japan.
Hideki Fujii, Yuichiro Suzuki, K. Sawada, M. Tatsuta, T. Maeshiro, Hiroshi Tobita, Tsubasa Tsutsumi, Takemi Akahane, C. Hasebe, M. Kawanaka, Takaomi Kessoku, Yuichiro Eguchi, Hayashi Syokita, A. Nakajima, T. Kamada, H. Yoshiji, T. Kawaguchi, H. Sakugawa, A. Morishita, Tsutomu Masaki, T. Ohmura, Toshio Watanabe, N. Kawada, Y. Yoda, N. Enomoto, M. Ono, Kanako Fuyama, Kazufumi Okada, Naoki Nishimoto, Yoichi M. Ito, Y. Kamada, Hirokazu Takahashi, Yoshio Sumida, Japan Study Group Of Nonalcoholic Fatty Liver Disease Jsg-Nafl   +33 more
semanticscholar   +1 more source

Lifestyle interventions in nonalcoholic fatty liver disease

Nature reviews: Gastroenterology & hepatology, 2023
Z. Younossi, S. Zelber-Sagi, Linda Henry, L. Gerber   +3 more
semanticscholar   +1 more source

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Ca-A Cancer Journal for Clinicians, 2018
Frank Bray, Jacques Ferlay, Isabelle Soerjomataram   +2 more
exaly  

Cancer statistics in China, 2015

Ca-A Cancer Journal for Clinicians, 2016
Rongshou Zheng, Peter D Baade, Siwei Zhang   +2 more
exaly